Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) EBT (2019 - 2025)

Historic EBT for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$31433.0.

  • Volitionrx's EBT rose 3319.09% to -$31433.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 3381.91%. This contributed to the annual value of -$27.0 million for FY2024, which is 2473.74% up from last year.
  • As of Q3 2025, Volitionrx's EBT stood at -$31433.0, which was up 3319.09% from $29992.0 recorded in Q2 2025.
  • Volitionrx's EBT's 5-year high stood at $94092.0 during Q4 2022, with a 5-year trough of -$9.5 million in Q2 2023.
  • For the 5-year period, Volitionrx's EBT averaged around -$2.9 million, with its median value being $9424.0 (2021).
  • Its EBT has fluctuated over the past 5 years, first surged by 79109.72% in 2022, then tumbled by 1258513.82% in 2023.
  • Volitionrx's EBT (Quarter) stood at $73088.0 in 2021, then increased by 28.74% to $94092.0 in 2022, then tumbled by 9380.53% to -$8.7 million in 2023, then soared by 33.8% to -$5.8 million in 2024, then surged by 99.46% to -$31433.0 in 2025.
  • Its EBT was -$31433.0 in Q3 2025, compared to $29992.0 in Q2 2025 and -$5.5 million in Q1 2025.